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ABSTRACT: We report here a general method 
for the synthesis of quaternary and tertiary 
difluoromethylated compounds and their 
vinylfluoride analogues. The strategy, which 
relies on a two-step sequence featuring a 
C-selective electrophilic difluoromethylation and 
either a palladium-catalyzed decarboxylative 
protonation or a Krapcho decarboxylation, is 
practical, scalable and high yielding. Considering 
the generality of the method and the attractive 
properties offered by the difluoromethyl group, 
this approach provides a valuable tool for late-stage functionalization and drug development. 
 
or several decades now, the introduction of fluorine 
atoms and fluorinated groups has drawn the attention of the 
synthetic organic chemistry community1 as these functional 
groups tend to exhibit enhanced properties compared to their 
non-fluorinated counterparts; these include greater metabolic 
stability, lipophilicity, membrane permeability and bio-
availability.2,3 The difluoromethyl group in particular was 
shown to exhibit a weak hydrogen bond donating ability and 
thus act as a bioisostere to carbinols, thiols, amides and 
hydroxamic acids.4 Interestingly, although fluorination and 
perfluoroalkylation reactions have now reached a certain 
maturity, the development of an efficient and reliable 
difluoromethylation reaction to access tertiary 
difluoromethylated compounds still remains a challenge.5 
Indeed, several limitations such as the choice of the 
difluoromethylating agent, its regioselectivity, its rather 
limited substrate scope and the stability of the 
difluoromethylated products themselves still preclude the use 
of this reaction as a reliable synthetic tool.6 While significant 
progress has recently been made to access quaternary 
difluoromethylated compounds through electrophilic 
C-selective difluoromethylation processes by Mikami,7a 
Kappe,7b Shen,7c Liu,7d Shibata7e and Hu7f (Figure 1), examples 
of methods affording tertiary difluoromethylated derivatives 
are still rather scarce. In this context, several effective 
difluoromethylating agents have been recently developed. 
Hu and co-workers, for instance, were the first to introduce a 
tosylsulfoximine based reagent to promote the 
difluoromethylation of C-nucleophiles (I, Figure 1)8 while 
Shibata and co-workers reported the sulfonium and 
sulfoxinium salts II and III (Figure 1), which both displayed 
high reactivity albeit moderate C/O selectivity.6,9 More 
recently, Shen,7c Liu7d and Shibata7e unveiled three new 
reagents (IV, V and VI, Figure 1) which induced excellent 
C-selectivities in the difluoromethylation of β-keto esters. 
These fundamental advances were completed by a recent study 
 
		
	
Figure	 1.	 Unified	 preparation	 of	 difluoromethyl	 and	 vinylfluoride-
containing	scaffolds. 
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by Hu and co-workers who generalized the use of TMSCF2Br 
(VI, Figure 1) to a larger range of C-centered nucleophiles.7f 
Surprisingly, while all of these reagents have been used to 
prepare quaternary difluoromethylated compounds, they all 
failed to provide the related tertiary derivatives. In this 
context, we were interested in developing a general method 
that would allow a straightforward access to a wide range of 
synthetically and biologically relevant quaternary (Q-CHF2) 
and tertiary (T-CHF2) C-difluoromethylated scaffolds as well 
as their vinylfluoride (V-CHF) analogues. As we will see, the 
combination of a highly C-selective difluoromethylation with 
either a palladium-catalyzed decarboxylative protonation or a 
Krapcho decarboxylation/dehydrofluorination enables a 
practical and scalable route to a variety of fluorinated building 
blocks (Figure 1).10,11 These methods were eventually applied 
to the late-stage functionalization of various natural products 
and APIs; we report here the results of our endeavor. 
The choice of the difluoromethylating agent was the 
starting point of our study. Indeed, several criteria needed to 
be met; ideally the difluoromethylating agent needed to exhibit 
high regioselectivity while the transient difluoromethylating 
species needed to be generated in an unbiased and controlled 
fashion to minimize any undesirable side reaction that could 
occur during the process. Hu’s reagent, S-(difluoromethyl)-S-
phenyl-N-tosylsulfoximine I, appeared as the perfect candidate 
as the generation of the difluorocarbene was proven to be 
solely induced by the enolate independently of the base 
used.8,12 Additionally, this solid and bench-stable reagent is 
easy to use and can be prepared on a multi-gram scale in only 
three steps starting from thiophenol.13 
To conduct the optimization of the difluoromethylation 
step, we chose N-Boc-protected β-methylester valerolactam 1 
as a model substrate. Interestingly, a complete C-selectivity of 
the reaction was observed; the desired C-difluoromethylated 
lactam 2a being the only product detected by 19F and 1H NMR 
of the crude reaction mixture. A thorough screening of the 
conditions showed the ineffectiveness of organic bases such as 
Et3N and DBU (Table 1, entries 1-2) and mild inorganic bases 
such as K2CO3 (see SI for a complete base screen). The use of 
stronger bases such as NaH, LiHMDS or KHMDS led to 
higher yields (Table 1, entries 3-5), however the best results 
were obtained with non-nucleophilic alkoxides such as 
potassium tert-butoxide, which afforded the desired lactam in 
66% yield (Table 1, entry 6). 
Both the concentration and the stoichiometry proved to be 
crucial for the reaction to proceed efficiently with 0.15 M 
concentration, 2.1 equiv. of base and 2 equiv. of I being the 
best conditions (Table 1, entry 8). A drastic loss in reactivity 
was observed when the "naked" enolate was engaged. Indeed, 
in the presence of 18-crown-6, the yield dropped from 66% to 
10% although 1 equiv. of I was consumed (Table 1, entry 9) 
thus clearly stressing the dual role of the enolate which acts 
both as a base and as a nucleophile. 
A thorough screening of the nature of the solvent showed 
the superiority of DCM over all the other solvents as the 
corresponding C-difluoromethylated product was obtained in 
69% yield after 6 h (See SI for a complete solvent screen). 
This yield could be further improved by simply conducting the 
reaction at −40 °C (81%, Table 1, entry 11). 
With these optimal conditions in hand, we naturally turned 
our attention towards the scope of the reaction. As a general 
trend, no discrepancies were observed when varying either the 
protecting group on the nitrogen atom, the nature of the ester 
Table	1.	Systematic	study.a	
	
aAll	reactions	were	run	on	a	0.1	mmol	scale	during	24	h.	I	is	added	after	stirring	1	with	the	base	
for	 30	 min.	 bYield	 determined	 by	 1H	 NMR	 using	 dibromomethane	 as	 an	 internal	 standard.	
cReaction	ran	using	2.1	equiv	of	18-crown-6.	dReaction	completed	after	12	h.	
 
or the scale of the reaction (2-5). This prompted us to use the 
less bulky Bn-protecting group for the rest of the study. Other 
six-membered ring heterocyclic scaffolds were evaluated such 
as glutaramides (6), quinolinones (7) and tetrahydro-
pyrimidine-2,4-diones (8); all afforded high yields ranging 
from 58% to 96%. Good to excellent reactivities were also 
observed with the smaller five-membered ring γ-lactams (9),10c 
succinimides (11) and oxindoles (12), as the corresponding 
C-difluoromethylated products were obtained in good to 
excellent yields ranging from 74% to 93%. Replacing the ester 
by a ketone was not detrimental to either the reactivity or the 
selectivity as the corresponding C-difluoromethylated product 
10 was obtained in 74% yield. The method could also be 
successfully applied to the seven-membered ring caprolactam 
14 and to the four-membered ring β-lactam 13, however the 
latter was isolated in only 17% yield. This was associated to 
the relative instability of the corresponding enolate 
intermediate. Finally, butyrolactones also proved to be good 
candidates as showcased by the moderate to good yields 
obtained for 15 and 16. Several attempts to conduct a direct 
α-difluoromethylation on substrates lacking the ester moiety 
were made, first on the Boc-protected δ-valerolactam itself 
and then on the Boc-protected δ-valerolactam bearing a phenyl 
substituent at the α-position, however no conversion was 
observed confirming the importance of the β-keto ester motif 
for the difluoromethylation step (see SI for more details). 
Keeping in mind our objective to provide a tool for the 
synthesis of tertiary difluoromethylated scaffolds, we decided 
to subject our quaternary difluoromethylated methyl ester 
derivative 3 to the traditional Krapcho decarboxylation 
conditions (DMSO, LiCl, H2O, heating). Unfortunately, 
instead of the desired decarboxylation product, we isolated the 
corresponding E-vinylfluoride analogue 17 in 92% yield 
(Figure 2). This outcome, most likely due to the increased 
acidity of the tertiary difluoromethylated intermediate which 
favors the loss of HF through an E1cb process, was actually 
also observed by Tunemoto and co-workers.16 Nonetheless, we 
decided to take advantage of this reactivity pattern to 
synthesize various key vinylfluoride derivatives. We rapidly 
realized that only 15 min were necessary to achieve full 
conversion, high yields and exclusive E stereoselectivity. 
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Figure	2.	aThe	reaction	was	run	in	THF	(0.1	M)	at	rt	for	3	d.	bYield	based	on	recovered	starting	material	(26%	isolated	yield).	cThe	reaction	was	allowed	to	
warm	up	to	rt	after	12	h	stirring	at	−40	°C	and	stirring	was	continued	at	the	same	temperature	for	an	additional	36	h. 
 
We believe this selectivity is due to the increased stability of 
the pro-E enolate intermediate obtained upon decarboxylation 
and the E1CB type mechanism which forces an anti-elimination 
(See SI for full discussion). In general, the 5-, 6- and 
7-membered ring lactams and quinolinones were readily 
converted to the corresponding vinylfluorides in good to 
excellent yields ranging from 61% to 96% (17-20, Figure 2). 
Slightly milder conditions were used in the case of the 
tetrahydropyrimidine-2,4-dione, glutaramide and succinimide 
derivatives due to stability issues, however the yields 
remained relatively high (21-23, Figure 2). Hence, although 
the oxindole derivative couldn’t be isolated, this metal-free, 
fast, trivial to set up and entirely diastereoselective sequence 
showed a relatively wide applicability as showcased by the 
various exocyclic (E)-monofluoroalkene derivatives obtained. 
In our effort to develop a viable route to tertiary 
difluoromethylated compounds17,18 and considering our 
expertise in the field of Pd-AAA,19 we next decided to 
investigate yet another route involving a palladium-catalyzed 
decarboxylative protonation of substrates bearing an activated 
allyl ester.20 Indeed, if successful, this would not only provide 
a straightforward access to the tertiary difluoromethylated 
scaffolds we were aiming for, it would also be the first 
example of a palladium-catalyzed decarboxylative protonation 
applied to a difluoromethylated precursor. A second and wider 
difluoromethylation scope was therefore conducted; the results 
are depicted in Figure 3. 
As expected, the differences between the allyl and the 
methyl esters in the difluoromethylation step were negligible; 
all the substrates engaged led to the C-difluoromethylated 
products in high yields ranging from 69% to 92% (24-31) with 
the exception of glutaramide 25 and butyrolactone 31 which 
were obtained in only 26% and 37% yield, respectively. 
Considering the importance of Weinreb amides in routine 
organic synthesis,11 we decided to apply the method to such 
compounds. We were pleased to observe that these acyclic 
scaffolds could also be successfully difluoromethylated in 
good to excellent yields ranging from 54% to 97% (Figure 3, 
32-39). The reaction proved to tolerate various substitution 
patterns at the α-position, from simple alkyls to more complex 
side chains without showing any side reactivity.  
Following these results, we next evaluated the palladium-
catalyzed decarboxylative protonation. Luckily, we rapidly 
managed to obtain the desired decarboxylated products by 
simply heating the allyl esters in the presence of Pd(OAc)2, 
dppe and formic acid.21 Lactams, glutaramides, succinimides 
and quinolinones all proved to be good candidates as the 
corresponding tertiary difluoromethylated compounds were 
obtained in good to high yields ranging from 59% to 87%, 
including the azapirone derivative 42.22 Most importantly, the 
reaction could be run on a gram scale without any noticeable 
loss in efficiency (40, Figure 3). The reaction also proved to 
be applicable to Weinreb amides as showcased by the 
formation of the corresponding tertiary difluoromethylated 
products 48-51 in yields ranging from 26% to 83%. 
The scope culminated with the application of this 
C-selective difluoromethylation to the late-stage 
functionalization of biologically relevant targets including 
natural products [matrine (53, 33%), sclareolide (54, 65%), 
pyroglutaminol (57, 44%)] and APIs [aniracetam (52, 45%), 
phensuximide (55, 60%)] (Figure 4). In the case of sclareolide, 
the difluoromethylation also proved to be remarkably 
stereoselective as the corresponding difluoromethylated 
product 54 was obtained as a single diastereomer. The 
difluoromethylated analogues of aniracetam, matrine and 
sclareolide were eventually subjected to the Pd-catalyzed 
decarboxylative protonation conditions and the desired tertiary 
difluoromethylated products 58, 59 and 60 were all obtained in 
good yields and an excellent diastereoselectivity in the case of 
the sesquiterpene lactone. Surprisingly, in the case of 
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Figure	3.	aThe	reactions	were	run	in	THF	(0.1	M)	at	room	temperature	for	3	d.	bYield	based	on	recovered	starting	material	(37%	isolated	yield). 
 
compounds 55, 56 and 57, the decarboxylation predominantly 
led to the vinylfluorides 61, 62 and 63 along with the desired 
tertiary difluoromethylated products due to the increased 
acidity of these compounds which favors the E1CB elimination 
process. To push the reaction towards the complete formation 
of the vinylfluoride derivatives, the crude reaction mixtures 
were adsorbed onto silica in the presence of Et3N, which 
allowed to isolate the phensuximide (61, 75%), costinone B23 
(62, 79%) and pyroglutaminol (63, 79%) derivatives in overall 
good yields and with an exclusive (E)-configuration. 
Interestingly, these last three compounds couldn’t be obtained 
under the Krapcho decarboxylation conditions, which 
showcases the complementarity between the two methods. 
Finally, the Yamazaki conditions [LDA, THF, −78 °C], 
initially developed for the dehydrofluorination of 
trifluoromethyl moieties, could also be applied (Figure 4, B),24 
while alternative post-functionalization reactions, including 
the conversion of valerolactam 3 to the corresponding amide 
64 [NH3, MeOH, reflux, 78% yield, Figure 4, C] and 
piperidine 65 [LiAlH4, THF, reflux, 52% yield, Figure 4, D] 
were relatively trivial (See SI for details). This latter result is 
all the more appealing since piperidines are arguably the most 
prevalent heterocycle in approved drugs.10a 
In summary, we have developed a highly straightforward, 
synthesis of both quaternary and tertiary difluoromethylated 
scaffolds and their (E)-vinylfluoride analogues. This strategy, 
which combines a C-selective difluoromethylation with either 
a palladium-catalyzed decarboxylative protonation or a 
Krapcho decarboxylation, is practical, usually high yielding 
and scalable. Moreover, it can be applied to the late-stage 
functionalization of natural products and APIs, which is 
particularly useful in the context of drug development. 
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Figure	 4.	 Late-stage	 functionalization	 of	 various	 natural	 products	 and	 APIs	 such	 as	 aniracetam,	 matrine,	 sclareolide,	 phensuximide,	 costinone	 B	 and	
pyroglutaminol.	aThe	reaction	was	run	using	3	equiv.	of	I	and	3.1	equiv.	of	t-BuOK	stirring	for	12	h	at	−40	°C	and	72	h	at	40	°C.	bYield	determined	by	NMR	
on	the	crude	reaction	mixture	using	an	internal	standard	(26%	isolated	yield).	
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